Aeffner Famke, Martin Nathan T, Peljto Mirza, Black Joshua C, Major Justin K, Jangani Maryam, Ports Michael O, Krueger Joseph S, Young G David
Flagship Biosciences Inc., Westminster, CO, USA.
Centre for Cancer and Inflammation, Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK.
Lab Invest. 2016 Dec;96(12):1327-1336. doi: 10.1038/labinvest.2016.111. Epub 2016 Oct 24.
Tissue image analysis (tIA) is emerging as a powerful tool for quantifying biomarker expression and distribution in complex diseases and tissues. Pancreatic ductal adenocarcinoma (PDAC) develops in a highly complex and heterogeneous tissue environment and, generally, has a very poor prognosis. Early detection of PDAC is confounded by limited knowledge of the pre-neoplastic disease stages and limited methods to quantitatively assess disease heterogeneity. We sought to develop a tIA approach to assess the most common PDAC precursor lesions, pancreatic intraepithelial neoplasia (PanIN), in tissues from Kras; Trp53; Pdx-Cre (KPC) mice, a validated model of PDAC development. tIA profiling of training regions of PanIN and tumor microenvironment (TME) cells was utilized to guide identification of PanIN/TME tissue compartment stratification criteria. A custom CellMap algorithm implementing these criteria was applied to whole-slide images of KPC mice pancreata sections to quantify p53 and Ki-67 biomarker staining in each tissue compartment as a proof-of-concept for the algorithm platform. The algorithm robustly identified a higher percentage of p53-positive cells in PanIN lesions relative to the TME, whereas no difference was observed for Ki-67. Ki-67 expression was also quantified in a human pancreatic tissue sample available to demonstrate the translatability of the CellMap algorithm to human samples. Together, our data demonstrated the utility of CellMap to enable objective and quantitative assessments, across entire tissue sections, of PDAC precursor lesions in preclinical and clinical models of this disease to support efforts leading to novel insights into disease progression, diagnostic markers, and potential therapeutic targets.
组织图像分析(tIA)正在成为一种强大的工具,用于量化复杂疾病和组织中生物标志物的表达和分布。胰腺导管腺癌(PDAC)在高度复杂和异质性的组织环境中发生,并且通常预后很差。由于对肿瘤前疾病阶段的了解有限以及定量评估疾病异质性的方法有限,PDAC的早期检测受到困扰。我们试图开发一种tIA方法,以评估Kras;Trp53;Pdx-Cre(KPC)小鼠组织中最常见的PDAC前体病变,即胰腺上皮内瘤变(PanIN),这是一种经过验证的PDAC发展模型。利用PanIN和肿瘤微环境(TME)细胞训练区域的tIA分析来指导PanIN/TME组织区室分层标准的识别。将实施这些标准的定制CellMap算法应用于KPC小鼠胰腺切片的全切片图像,以量化每个组织区室中p53和Ki-67生物标志物的染色,作为该算法平台的概念验证。该算法稳健地识别出PanIN病变中p53阳性细胞的比例高于TME,而Ki-67未观察到差异。还对一份可用的人类胰腺组织样本中的Ki-67表达进行了量化,以证明CellMap算法对人类样本的可转移性。总之,我们的数据证明了CellMap在临床前和临床模型中对整个组织切片进行客观和定量评估PDAC前体病变的实用性,以支持对疾病进展、诊断标志物和潜在治疗靶点的新见解的研究。